Literature DB >> 19389151

Hippocampal distribution of vesicular glutamate transporter 1 in patients with temporal lobe epilepsy.

W Saskia van der Hel1, Suzanne A M W Verlinde, Dimphna H M Meijer, Marina de Wit, Marije G Rensen, Koen L I van Gassen, Peter C van Rijen, Cees W M van Veelen, Pierre N E de Graan.   

Abstract

PURPOSE: Vesicular glutamate transporters (VGLUTs) are responsible for loading synaptic vesicles with glutamate, determining the phenotype of glutamatergic neurons, and have been implicated in the regulation of quantal size and presynaptic plasticity. We analyzed VGLUT subtype expression in normal human hippocampus and tested the hypothesis that alterations in VGLUT expression may contribute to long-term changes in glutamatergic transmission reported in patients with temporal lobe epilepsy (TLE).
METHODS: VGLUT immunohistochemistry, immunofluorescence, in situ hybridization, Western blotting, and quantitative polymerase chain reaction (qPCR) were performed on biopsies from TLE patients without (non-HS) and with hippocampal sclerosis (HS) and compared to autopsy controls and rat hippocampus. VGLUT1 expression was compared with synaptophysin, neuropeptide Y (NPY), and Timm's staining.
RESULTS: VGLUT1 was the predominant VGLUT in human hippocampus and appeared to be localized to presynaptic glutamatergic terminals. In non-HS hippocampi, VGLUT1 protein levels were increased compared to control and HS hippocampi in all subfields. In HS hippocampi VGLUT1 expression was decreased in subfields with severe neuronal loss, but strongly up-regulated in the dentate gyrus, characterized by mossy fiber sprouting. DISCUSSION: VGLUT1 is used as marker for glutamatergic synapses in the human hippocampus. In HS hippocampi VGLUT1 up-regulation in the dentate gyrus probably marks new glutamatergic synapses formed by mossy fiber sprouting. Our data indicate that non-HS patients have an increased capacity to store glutamate in vesicles, most likely due to an increase in translational processes or upregulation of VGLUT1 in synapses from afferent neurons outside the hippocampus. This up-regulation may increase glutamatergic transmission, and thus contribute to increased extracellular glutamate levels and hyperexcitability.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19389151     DOI: 10.1111/j.1528-1167.2009.02054.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  16 in total

Review 1.  Mechanisms of Excessive Extracellular Glutamate Accumulation in Temporal Lobe Epilepsy.

Authors:  Jan Albrecht; Magdalena Zielińska
Journal:  Neurochem Res       Date:  2016-11-21       Impact factor: 3.996

2.  Repeated low level domoic acid exposure increases CA1 VGluT1 levels, but not bouton density, VGluT2 or VGAT levels in the hippocampus of adult mice.

Authors:  Caitlin E Moyer; Emma M Hiolski; David J Marcinek; Kathi A Lefebvre; Donald R Smith; Yi Zuo
Journal:  Harmful Algae       Date:  2018-09-05       Impact factor: 4.273

3.  Collateral damage and compensatory changes after injection of a toxin targeting neurons with the neurokinin-1 receptor in the nucleus tractus solitarii of rat.

Authors:  Li-Hsien Lin; Deidre Nitschke Dragon; William T Talman
Journal:  J Chem Neuroanat       Date:  2012-03-06       Impact factor: 3.052

4.  Cleavage of the vesicular GABA transporter under excitotoxic conditions is followed by accumulation of the truncated transporter in nonsynaptic sites.

Authors:  João R Gomes; Andrea C Lobo; Carlos V Melo; Ana R Inácio; Jiro Takano; Nobuhisa Iwata; Takaomi C Saido; Luís P de Almeida; Tadeusz Wieloch; Carlos B Duarte
Journal:  J Neurosci       Date:  2011-03-23       Impact factor: 6.167

Review 5.  Physiological bases of the K+ and the glutamate/GABA hypotheses of epilepsy.

Authors:  Mauro DiNuzzo; Silvia Mangia; Bruno Maraviglia; Federico Giove
Journal:  Epilepsy Res       Date:  2014-04-21       Impact factor: 3.045

6.  A new VGLUT-specific potent inhibitor: pharmacophore of Brilliant Yellow.

Authors:  Yutaka Tamura; Kiyokazu Ogita; Tetsufumi Ueda
Journal:  Neurochem Res       Date:  2013-11-19       Impact factor: 3.996

7.  Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus.

Authors:  A Ludányi; S S-J Hu; M Yamazaki; A Tanimura; D Piomelli; M Watanabe; M Kano; K Sakimura; Z Maglóczky; K Mackie; T F Freund; I Katona
Journal:  Neuroscience       Date:  2010-10-28       Impact factor: 3.590

Review 8.  Are vesicular neurotransmitter transporters potential treatment targets for temporal lobe epilepsy?

Authors:  Joeri Van Liefferinge; Ann Massie; Jeanelle Portelli; Giuseppe Di Giovanni; Ilse Smolders
Journal:  Front Cell Neurosci       Date:  2013-08-30       Impact factor: 5.505

9.  A stereological study of synapse number in the epileptic human hippocampus.

Authors:  Lidia Alonso-Nanclares; Asta Kastanauskaite; Jose-Rodrigo Rodriguez; Juncal Gonzalez-Soriano; Javier Defelipe
Journal:  Front Neuroanat       Date:  2011-02-24       Impact factor: 3.856

10.  Analysis of intraoperative human brain tissue transcriptome reveals putative risk genes and altered molecular pathways in glioma-related seizures.

Authors:  Anteneh M Feyissa; Anna Carrano; Xue Wang; Mariet Allen; Nilüfer Ertekin-Taner; Dennis W Dickson; Mark E Jentoft; Steven S Rosenfeld; William O Tatum; Anthony L Ritaccio; Hugo Guerrero-Cázares; Alfredo Quiñones-Hinojosa
Journal:  Epilepsy Res       Date:  2021-03-18       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.